Zero-step coverage has nearly tripled since 2024†‡
In 2024,2
89% of nationally commercially insured lives had coverage for QULIPTA‡
22%
had zero-step coverage†‡
In 2026,2
national commercial coverage for QULIPTA improved to 98%‡
64%
had zero-step coverage†‡
Local coverage
Look up local coverage FOR QULIPTA IN YOUR AREA§
- Plan Name
- Plan type
- QULIPTA coverage
- Plan Name
- Plan type
- QULIPTA coverage
§Managed Markets Insight & Technology, LLCTM, a trademark of MMIT. Data as of May 2026 and subject to change.
Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.
Medicare Part D coverage
60%
of Medicare Part D lives now require zero steps to get QULIPTA3†§
Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.
*Highest Approval rates—Source: IQVIA LAAD Lifecycle Claims. Commercial NBRx from January 2025-December 2025 and subject to change. Preventive CGRP targeting therapies includes QULIPTA, Nurtec, Aimovig, Ajovy, Emgality.
†Zero-step coverage means the patient does not need to try and fail a prior therapy.
‡AbbVie internal analytics and Managed Markets Insight & Technology, LLCTM, a trademark of MMIT. Data as of January 2024 and August 2026 and subject to change.
§AbbVie internal analytics and Managed Markets Insight & Technology, LLCTM, a trademark of MMIT. Data as of January 2026.
QULIPTA Complete can help your patients start and stay on track with QULIPTA
Encourage your patients to sign up for the QULIPTA Complete Savings Card
97%
of commercially insured patients pay $0¶ using their QULIPTA Complete Savings Card3#
Not actual card.
With the QULIPTA Complete Savings Card, eligible commercially insured patients may pay as little as $0¶ a month
- For covered patients
- And while insurance coverage is being established
Card savings are applied to patients’ out-of-pocket costs, including their deductible.
¶Eligibility: Available to patients with commercial insurance coverage for QULIPTA who meet eligibility criteria. This copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs), or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit QULIPTASavingsCard.com or call 1-855-QULIPTA (1-855-785-4782) for more information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
#Data on File. AbbVie Inc. (Savings card redemption data as of January 2025–December 2025 and subject to change.)
Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.
CGRP=calcitonin gene-related peptide; ICD-10=International Classification of Diseases, 10th revision.
